Therma Bright Inc TBRIF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.01
- Day Range
- $0.01–0.01
- 52-Week Range
- $0.01–0.06
- Bid/Ask
- $0.00 / $0.02
- Market Cap
- $2.21 Mil
- Volume/Avg
- 100,000 / 106,200
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 98.46
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Therma Bright Inc is a medical diagnostic and device technology company focused on providing consumers and medical professionals with solutions to address important medical and healthcare challenges. The Company’s initial proprietary technology delivers non-invasive and pain-free skincare. The company's products include AcuVid, InterceptCS, Benepod, Venowave, TheroZap, Inretio and others.TherOZap and InterceptCS. The InterceptCS system provides controlled topical heat, without the risk of burning the skin, which will naturally prevent cold sore outbreaks. The TherOZap thermal therapy reduces the inflammatory response, relieving the symptoms of pain, itch, and inflammation associated with bites and stings.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- —
- Website
- https://www.thermabright.com
Valuation
|
Metric
|
TBRIF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 98.46 |
Price/Cash Flow | — |
Price/Earnings
TBRIF
Financial Strength
|
Metric
|
TBRIF
|
|---|---|
Quick Ratio | 0.02 |
Current Ratio | 0.12 |
Interest Coverage | −257.75 |
Quick Ratio
TBRIF
Profitability
|
Metric
|
TBRIF
|
|---|---|
Return on Assets (Normalized) | −89.65% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −190.88% |
Return on Assets
TBRIF
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Dccjrsnl | Ttxdzg | $182.7 Bil | |
SYK
| Stryker Corp | Mmbvfwnfq | Dwwn | $124.6 Bil | |
MDT
| Medtronic PLC | Clbsqnz | Ysbrxv | $105.2 Bil | |
BSX
| Boston Scientific Corp | Cdgnpqgdx | Nflnk | $99.1 Bil | |
EW
| Edwards Lifesciences Corp | Lslczgjxm | Sxgbk | $52.0 Bil | |
DXCM
| DexCom Inc | Shqbjmtnz | Jwpm | $51.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Hsgwdrgbn | Wjf | $24.5 Bil | |
ALGN
| Align Technology Inc | Pvvvfzs | Zkzcvt | $22.7 Bil | |
PHG
| Koninklijke Philips NV ADR | Rpvrvvbv | Rqnltk | $18.3 Bil | |
PODD
| Insulet Corp | Bnnljmgdmk | Dvwjb | $11.6 Bil |